
    
      In this prospective, multi-center, randomized controlled study, 176 patients who were
      diagnosed with varicose veins and met the inclusion criteria without any exclusion criteria
      were randomly divided into the experimental group (Hongyuan Endovenous Radiofrequency
      Ablation Closure System)and control group (Medtronic's ClosureFastâ„¢ Radiofrequency Ablation
      System) at 1:1. The effectiveness of the product was evaluated by the vascular closure rate
      at 6 months after the operation, and the safety of the product was evaluated by the incidence
      of adverse events and serious adverse events within 6 months after the operation.
    
  